Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
162.61B
Market cap162.61B
Price-Earnings ratio
38.03
Price-Earnings ratio38.03
Dividend yield
5.99%
Dividend yield5.99%
Average volume
34.83M
Average volume34.83M
High today
$28.48
High today$28.48
Low today
$28.43
Low today$28.43
Open price
$28.80
Open price$28.80
Volume
90.45K
Volume90.45K
52 Week high
$29.21
52 Week high$29.21
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $28.44. The company's market cap stands at 162.61B, with a P/E ratio of 38.03 and a dividend yield of 5.99%.

During the trading session on 2026-10-01, Pfizer(PFE) shares reached a daily high of $28.48 and a low of $28.43. At a current price of $28.44, the stock is +0.0% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 90.45K, compared to an average daily volume of 34.83M.

The stock's 52-week range extends from a low of $23.62 to a high of $29.21.

The stock's 52-week range extends from a low of $23.62 to a high of $29.21.

PFE News

TipRanks 1h
Pfizer says Phase 2 study of tilrekimig met primary endpoint

Pfizer (PFE) presented detailed results from an ongoing Phase 2 study investigating tilrekimig in adults with moderate-to-severe atopic dermatitis. The study me...

Nasdaq 2d
With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?

Key Points Pfizer is facing several headwinds, which have weighed on its financial results. The company isn't currently generating enough cash to cover its hi...

With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?
Nasdaq 2d
PFE Dividend Yield Pushes Past 6%

Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Pfizer Inc (Symbol: PFE) were yielding above the 6% mark based...

PFE Dividend Yield Pushes Past 6%

Analyst ratings

61%

of 28 ratings
Buy
32.1%
Hold
60.7%
Sell
7.1%

More PFE News

TipRanks 2d
Nurix Therapeutics announces achievement of $7M milestone with Pfizer

Nurix Therapeutics (NRIX) announced the achievement of a $7M research milestone under its strategic collaboration with Pfizer (PFE) for the discovery and develo...

Zacks 3d
Here is What to Know Beyond Why Pfizer Inc. is a Trending Stock

Pfizer (PFE Quick QuotePFE - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the fact...

Here is What to Know Beyond Why Pfizer Inc. is a Trending Stock
Simply Wall St 4d
Pfizer Heads Into Its London Conference, Is The Stock Fully Priced?

Pfizer (PFE) is heading into its U.S. All Stars Conference appearance in London on 22 September 2026 with investors weighing its shareholder payouts, recent acq...

Pfizer Heads Into Its London Conference, Is The Stock Fully Priced?
TipRanks 5d
Pfizer Bets Big on RSV and Cancer Care

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is quietly building new pillars of growt...

Nasdaq 6d
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?

Key Points AbbVie is transitioning its revenue base toward newer immunology drugs to offset the decline of its legacy treatments. Pfizer is leaning on heavy i...

AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
Seeking Alpha 6d
Pfizer shares rose for seven consecutive sessions

Pfizer (PFE) shares clocked seven straight sessions of gains, as the stock was up 1% at $28.68 on Friday. The global biopharmaceutical company gained 2.8% in t...

Pfizer shares rose for seven consecutive sessions
TipRanks 6d
Pfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is launching a new study to test ponsegromab in adults with non-small c...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.